The LGRC was established through an $11 million grant from the National Heart, Lung, and Blood Institute (NHLBI), which is funding the first two years of the project. This generous award is provided through funds appropriated for the National Institutes of Health Recovery Act as part of the American Recovery and Reinvestment Act (ARRA)—the “stimulus bill” enacted by Congress in 2009. LGRC funds are being used to hire and train new scientists in the growing field of genomic medicine, support existing research staff, and purchase the sophisticated equipment and supplies necessary to run the project—all of which are tangible outcomes that will benefit both individuals and the nation for years to come.
The LGRC project is an investment in our future. The award that is making it possible represents a commitment on behalf of the federal government to advance lung disease research and to ultimately improve lung health for all Americans. Together with the NHLBI as our partner, we can change the course of lung disease research and treatment.